SummaryModeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from the somatic cells of patients has provided a means of elucidating pathogenic mechanisms and performing drug screening. T cells are an ideal source of patient-specific iPSCs because they can be easily obtained from samples. Recent studies indicated that iPSCs retain an epigenetic memory relating to their cell of origin that restricts their differentiation potential. The classical method of differentiation via embryoid body formation was not suitable for T cell-derived iPSCs (TiPSCs). We developed a neurosphere-based robust differentiation protocol, which enabled TiPSCs to differentiate into functional neurons, despite differences in global gene...
iPSCs (induced pluripotent stem cells) are the newest tool used to model PD (Parkinson's disease). F...
The high attrition rate in drug development processes calls for additional human-based model systems...
In patients with Parkinson’s disease (PD), stem cells can serve as therapeutic agents to restore or ...
SummaryModeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from t...
Modeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from the soma...
Among the disciplines of medicine, the study of neurological disorders is particularly challenging. ...
Parkinson’s disease (PD) is characterized by progressive neurodegeneration that primarily depletes d...
Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluri...
Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluri...
Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryoni...
Adult cells from patients can be reprogrammed to induced pluripotent stem cells (iPSCs) which succes...
Many human neurological diseases are not currently curable and result in devastating neurologic sequ...
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons....
Zhifang Qiu,1,2 Steven L Farnsworth,2 Anuja Mishra,1,2 Peter J Hornsby1,21Geriatric Research Educati...
Cellular reprogramming of somatic cells to human pluripotent stem cells (iPSC) represents an efficie...
iPSCs (induced pluripotent stem cells) are the newest tool used to model PD (Parkinson's disease). F...
The high attrition rate in drug development processes calls for additional human-based model systems...
In patients with Parkinson’s disease (PD), stem cells can serve as therapeutic agents to restore or ...
SummaryModeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from t...
Modeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from the soma...
Among the disciplines of medicine, the study of neurological disorders is particularly challenging. ...
Parkinson’s disease (PD) is characterized by progressive neurodegeneration that primarily depletes d...
Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluri...
Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluri...
Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryoni...
Adult cells from patients can be reprogrammed to induced pluripotent stem cells (iPSCs) which succes...
Many human neurological diseases are not currently curable and result in devastating neurologic sequ...
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons....
Zhifang Qiu,1,2 Steven L Farnsworth,2 Anuja Mishra,1,2 Peter J Hornsby1,21Geriatric Research Educati...
Cellular reprogramming of somatic cells to human pluripotent stem cells (iPSC) represents an efficie...
iPSCs (induced pluripotent stem cells) are the newest tool used to model PD (Parkinson's disease). F...
The high attrition rate in drug development processes calls for additional human-based model systems...
In patients with Parkinson’s disease (PD), stem cells can serve as therapeutic agents to restore or ...